Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer

Journal of the National Cancer Institute

Volumn 89, Issue 4, 1997, Pages 308-313

  Johnston, Patrick G ^a,d   Mick, Rosemarie ^b   Recant, Wendy ^b   Behan, Katherine A ^a   Dolan, M Eileen ^b   Ratain, Mark J ^b   Beckmann, Enrique ^c   Weichselbaum, Ralph R ^b   Allegra, Carmen J ^a   Vokes, Everett E ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c MICHAEL REESE HOSPITAL   (United States)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; CISPLATIN; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; PIRITREXIM; THYMIDYLATE SYNTHASE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; DNA SYNTHESIS; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

EID: 0031019404     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.4.308     Document Type: Article

References (31)

1. Grem JL. Fluorinated pyrimidines. In: Chabner BA, Collins JM, editors. Cancer chemotherapy, principles and practice. Philadelphia: Lippincott, 1990:180-224.
2. Grem JL. 5-Fluorouracil plus leucovorin in cancer therapy. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. Principles and practice of oncology update series, 2(7) July. Philadelphia: Lippincott, 1988.
3. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993;328:184-94.
4. Dreyfuss AI, Clark JR, Wright JE, Norris CM Jr, Busse PM, Lucarini JW, et al. Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck. Ann Intern Med 1990;112:167-72.
5. Washtien WL. Increased levels of thymidylate synthetase in cells exposed to 5-fluorouracil. Mol Pharmacol 1984;25:171-7.
6. Clark JL, Berger SL, Mittelman A, Berger FG. Thymidylate synthase gene amplification in a colon tumor resistant to fluoropyrimidine chemotherapy. Cancer Treat Rep 1987;71:261-5.
7. Johnston PG, Drake JC, Trepel J, Allegra CJ. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines. Cancer Res 1992;52: 4306-12.
8. Chu E, Koeller DM, Johnston PG, Zinn S, Allegra CJ. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma. Mol Pharmacol 1993;43:527-33.
9. Chu E, Zinn S, Boarman D, Allegra CJ. The interaction of γ interferon and 5-fluorouracil in the H630 human colon carcinoma cell line. Cancer Res 1990;50:5834-40.
10. Swain SM, Lippman ME, Egan EF, Drake JC, Steinberg SM, Allegra CJ. Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer. J Clin Oncol 1989;7:890-9.
11. Johnston PG, Liang CM, Henry S, Chabner BA, Allegra CJ. Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue. Cancer Res 1991;51: 6668-76.
12. Clark J, Busse P, Norris CJ, Dreyfress A, Rossi R, Poulin M, et al. Long term results of induction chemotherapy with cisplatin, 5-FU and high dose leucovorin (PFL) for squamous cell carcinoma of the head and neck. Proc ASCO 1996;897:317.
13. Vokes EE, Weichselbaum RR, Mick R, McEvilly JM, Haraf D, Panje WR. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. J Natl Cancer Inst 1992;84:877-82.
14. Vokes EE, Schilsky RL, Weichselbaum RR, Kozloff MF, Panje WR. Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis. J Clin Oncol 1990;8:241-7.
15. Vokes EE, Haraf DJ, McEvilly JM, Mick R, Kozloff MF, Goldman MD, et al. Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: a feasible and active approach. Ann Oncol 1992;3:79-81.
16. Vokes EE, Ratain MJ, Mick R, McEvilly JM, Haraf D, Kozloff M, et al. Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis [published erratum appears in J Clin Oncol 1994;12:643]. J Clin Oncol 1993;11:360-8.
17. Vokes EE, Kies M, Haraf DJ, Mick R, Moran WJ, Kozloff M, et al. Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease. J Clin Oncol 1995;13:876-83.
18. Vokes EE, Mick R, Kies MS, Dolan E, Malone D, Athanasiades I, et al. Pharmacodynamics of fluorouracil based induction chemotherapy in advanced head and neck cancer. J Clin Oncol. In press.
19. Hsu SM, Raine L, Fanger H. Use of avidinbiotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
20. American Joint Committee on Cancer. Head and Neck Cancer. In: Beahrs OH, Henson DE, Hutter RV, Myers MH, editors. Manual for staging of cancer. 3rd ed. Philadelphia: Lippincott, 1988:51-6.
21. Armitage P. Test for linear trend in proportions and frequencies. Biometrics 1955;11:375-86.
22. Holland M. Wolfe DA. Nonparametric statistical methods. New York: Wiley, 1958.
23. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
24. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
25. Chu E, Koeller DM, Casey JL, Drake JC, Chabner BA, Elwood PC, et al. Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. Proc Natl Acad Sci U S A 1991;88:8977-81.
26. Johnston PG, Fisher ER, Rockette HE, Fisher B, Wolmark N, Drake JC, et al. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 1994;12: 2640-7.
27. Johnston PG, Lenz HJ, Leichman CG, Danenberg KD, Allegra CJ, Danenberg PV, et al. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 1995;55:1407-12.
28. Lenz HJ, Leichman CG, Danenberg KD, Danenberg PV, Groshen S, Cohen H, et al. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J Clin Oncol 1995;14:176-82.
29. Peters GJ, van der Wilt CL, van Groeningen CJ, Smid K, Meijer S, Pinedo HM. Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil. J Clin Oncol 1995; 12: 2035-42.
30. Alexander HR, Grem JL, Hamilton JM, Pass HI, Hong M, McAtee N, et al. Thymidylate synthase protein expression is associated with response following neoadjuvant chemotherapy and resection for locally advanced gastric cancer. Cancer J 1995;1:49-54.
31. Etienne MC. Cheradame S, Fischel P, Formento P, Dassonville O, Renee N, et al. Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity. J Clin Oncol 1995;13: 1663-70.